- Home
- VINP vs EYPT Comparison
VINP vs EYPT Comparison
Compare VINP & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- EYPT
- Stock Information
- Founded
- VINP 2009
- EYPT 1987
- Country
- VINP Brazil
- EYPT United States
- Employees
- VINP N/A
- EYPT N/A
- Industry
- VINP Investment Managers
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- VINP Finance
- EYPT Industrials
- Exchange
- VINP Nasdaq
- EYPT Nasdaq
- Market Cap
- VINP 593.2M
- EYPT 579.4M
- IPO Year
- VINP 2021
- EYPT 2005
- Fundamental
- Price
- VINP $9.77
- EYPT $10.15
- Analyst Decision
- VINP Strong Buy
- EYPT Strong Buy
- Analyst Count
- VINP 2
- EYPT 8
- Target Price
- VINP $13.25
- EYPT $24.75
- AVG Volume (30 Days)
- VINP 55.8K
- EYPT 784.9K
- Earning Date
- VINP 08-06-2025
- EYPT 08-06-2025
- Dividend Yield
- VINP 6.65%
- EYPT N/A
- EPS Growth
- VINP N/A
- EYPT N/A
- EPS
- VINP 0.38
- EYPT N/A
- Revenue
- VINP $126,696,258.00
- EYPT $56,042,000.00
- Revenue This Year
- VINP $70.28
- EYPT N/A
- Revenue Next Year
- VINP $14.37
- EYPT N/A
- P/E Ratio
- VINP $25.66
- EYPT N/A
- Revenue Growth
- VINP 57.51
- EYPT 12.04
- 52 Week Low
- VINP $8.66
- EYPT $3.91
- 52 Week High
- VINP $11.62
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- VINP 54.87
- EYPT 62.47
- Support Level
- VINP $9.43
- EYPT $8.96
- Resistance Level
- VINP $9.94
- EYPT $10.20
- Average True Range (ATR)
- VINP 0.25
- EYPT 0.76
- MACD
- VINP 0.03
- EYPT -0.03
- Stochastic Oscillator
- VINP 70.65
- EYPT 62.90
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.